💊 A new international clinical trial found that oral semaglutide ... population prone to heart attacks, strokes, and related complications, showing similar benefits to its injectable counterpart.

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide ... benefits they’re looking for. Some patients with a personal or family history of heart ...

McGuire, MD, MHSc, professor of medicine in the division of cardiology, Dallas Heart Ball Chair ... support the fact that oral semaglutide will generate the same CV benefits as the rest of the ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

“Heart attacks and ... SOUL published simultaneously, oral semaglutide reduced risk of MACE independently of baseline use of SGLT2i and suggests similar benefits in participants with and without ...

It helps protect the heart too,” they said ... the U.S. and Europe to update the labelling of oral semaglutide to reflect its cardiovascular benefits. A decision is anticipated in 2025.

Oral semaglutide reduced major cardiovascular events by 14% in patients with type 2 diabetes over nearly 4 years. The trial involved 9650 patients with type 2 diabetes and cardiovascular or kidney ...

The following is a summary of “Oral semaglutide for the treatment of obesity: a retrospective real-world study,” published in ...

Early heart benefits before major weight changes One of the most intriguing aspects of semaglutide’s cardiovascular impact is the timing of these benefits. Recent analysis of extensive clinical ...

Benefits of Semaglutide Well Known The US Food and Drug Administration requires that all new medications for type 2 diabetes clear a cardiovascular safety hurdle before approval, and oral semaglutide ...

The researchers saw a 26% reduction in non-fatal heart attacks with oral semaglutide and a 12% reduction ... “The same cardiovascular benefits can be derived from the tablet that we’ve seen ...